146 related articles for article (PubMed ID: 1451057)
1. Prognostic factor of telecobalt therapy for early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Cancer; 1992 Dec; 70(12):2797-801. PubMed ID: 1451057
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in telecobalt therapy for early supraglottic carcinoma.
Inoue T; Matayoshi Y; Inoue T; Ikeda H; Teshima T; Murayama S
Cancer; 1993 Jul; 72(1):57-61. PubMed ID: 8508430
[TBL] [Abstract][Full Text] [Related]
3. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
[TBL] [Abstract][Full Text] [Related]
4. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
5. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
[TBL] [Abstract][Full Text] [Related]
6. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in early glottic carcinoma.
Kanonier G; Fritsch E; Rainer T; Thumfart WF
Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):759-63. PubMed ID: 8865769
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
13. Cancer of the glottis: prognostic factors in radiation therapy.
Mantravadi RV; Liebner EJ; Haas RE; Skolnik EM; Applebaum EL
Radiology; 1983 Oct; 149(1):311-4. PubMed ID: 6611940
[TBL] [Abstract][Full Text] [Related]
14. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy of T1N0 neoplasms of the glottis. Analysis of the parameters that influence local control].
Bolner A; Valentini A; Amichetti M; Busana L; Fellin G; Menegotti L; Nassivera E; Pani G; Romano M
Radiol Med; 1995 Dec; 90(6):804-7. PubMed ID: 8685467
[TBL] [Abstract][Full Text] [Related]
16. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
Lim YJ; Wu HG; Kwon TK; Hah JH; Sung MW; Kim KH; Park CI
Cancer Res Treat; 2015 Oct; 47(4):862-70. PubMed ID: 25687859
[TBL] [Abstract][Full Text] [Related]
18. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
